RxDoctor Payments Data

Anne Lucky, MD

Pediatric Dermatology · Cincinnati, OHNPI 1285688150

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations.

$437in general payments, 2019–2025

Across 23 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$61
  • Galderma Laboratories, L.p.$59
  • Amgen$48
  • Dermavant Sciences, Inc.$48
  • Lilly USA, LLC$36
  • Novartis$33
  • plus $152 from 7 others
$301,536in research payments, 2019–2025

Across 18 payments — averaging $16,752 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Krystal Biotech Inc$265K
  • Amryt Pharma Holdings Ltd$37K

What the payments were for

  • Food & beverage$437100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few pediatric dermatology providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,034
Medicare patients
16
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate22$789
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox15$601
Ketoconazole12$222

Paid to pharmacies, not to this prescriber.

Other pediatric dermatology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →